Form D — Rinascera Therapeutics, Inc.
0002090779-25-000001 · filed Oct 8, 2025
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $2,500,000
- Total sold
- $2,500,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Rinascera Therapeutics, Inc.
- CIK
- 2090779
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2025
- Address
- 75 KNEELAND ST FL 14
BOSTON, MA 02111 - Phone
- (408) 396-3123
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Nichola Eliovits · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
Max Dawson · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
Karl Beutner · Executive OfficerBOSTON, MA Find on LinkedIn ↗
-
Daniel Yadegar · DirectorBOSTON, MA Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗